Ethnicity-specific BRCA1, BRCA2, PALB2, and ATM pathogenic alleles in breast and ovarian cancer patients from the North Caucasus

被引:0
作者
Anna P. Sokolenko
Elvina Kh. Bakaeva
Aigul R. Venina
Ekaterina Sh. Kuligina
Alexandr A. Romanko
Svetlana N. Aleksakhina
Yana V. Belysheva
Evgeniya V. Belogubova
Ilya A. Stepanov
Olga A. Zaitseva
Olga S. Yatsuk
Alexandr V. Togo
Zaur M. Khamgokov
Azinat O. Kadyrova
Albert Sh. Pirmagomedov
Marina B. Bolieva
Alexandr A. Epkhiev
Aslan K. Tsutsaev
Madina D. Chakhieva
Khalimat M. Khabrieva
Idris M. Khabriev
Mirza A. Murachuev
Bella N. Buttaeva
Liliya S. Baboshkina
Fatima I. Bayramkulova
Islam R. Katchiev
Lina Kh. Alieva
Grigory A. Raskin
Sergey V. Orlov
Zarema K. Khachmamuk
Karine R. Levonyan
Dariya M. Gichko
Dmitriy V. Kirtbaya
Alexey M. Degtyariov
Luisa V. Sultanova
Hedi S. Musayeva
Alexey M. Belyaev
Evgeny N. Imyanitov
机构
[1] N.N. Petrov Institute of Oncology,Department of Tumor Growth Biology
[2] St. Petersburg Pediatric Medical University,Republican Cancer Center
[3] The Kabardino-Balkarian Republic,City Hospital No.1
[4] The Kabardino-Balkarian Republic,Republican Cancer Center
[5] The Republic of North Ossetia-Alania,Republican Cancer Center
[6] The Republic of Ingushetia,Republican Cancer Center
[7] The Republic of Dagestan,Republican Bureau of Pathology
[8] The Republic of Dagestan,Republican Cancer Center
[9] The Karachay-Cherkess Republic,undefined
[10] Dr. Sergey Berezin Medical Institute of Biological Systems,undefined
[11] I.P. Pavlov St.-Petersburg State Medical University,undefined
[12] Regional Clinical Cancer Center,undefined
[13] City Cancer Center,undefined
[14] Republican Cancer Center,undefined
来源
Breast Cancer Research and Treatment | 2024年 / 203卷
关键词
Founder effect; Hereditary cancer; North Caucasus; Pathogenic variants;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:307 / 315
页数:8
相关论文
共 333 条
[1]  
Miki Y(1994)A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 Science 266 66-71
[2]  
Swensen J(1995)Identification of the breast cancer susceptibility gene BRCA2 Nature 378 789-792
[3]  
Shattuck-Eidens D(1996)Genetic heterogeneity in hereditary breast cancer: role of BRCA1 and BRCA2 Am J Hum Genet 59 547-553
[4]  
Futreal PA(2010)Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene Nat Genet 42 410-414
[5]  
Harshman K(2015)Contribution of germline mutations in the RAD51B, RAD51C, and RAD51D genes to ovarian cancer in the population J Clin Oncol 33 2901-2907
[6]  
Tavtigian S(2017)Contribution of germline deleterious variants in the RAD51 paralogs to breast and ovarian cancers Eur J Hum Genet 25 1345-1353
[7]  
Liu Q(2020)BRIP1, RAD51C, and RAD51D mutations are associated with high susceptibility to ovarian cancer: mutation prevalence and precise risk estimates based on a pooled analysis of ~30,000 cases J Ovarian Res 13 50-506
[8]  
Cochran C(2014)Breast-cancer risk in families with mutations in PALB2 N Engl J Med 371 497-68
[9]  
Bennett LM(2022)Moderate-risk genes for hereditary ovarian cancers involved in the homologous recombination repair pathway Int J Mol Sci 23 11790-235
[10]  
Ding W(2023)Hereditary cancer syndromes World J Clin Oncol 14 40-30